Conclusion
diabetes
DIABETES
Both Omnipod and A7+TouchCare pumps showed similar performance to achieve glycemic control in patients with diabetes and the level of satisfaction was quite similar between groups. Although patients preferred the Omnipod as insulin management system and more specifically the patch delivery system (POD) of the Omnipod pump, they seem to prefer the PDM of the A7+TouchCare system for controlling and managing their pump. Overall, the A7+TouchCare may be a valuable alternative to Omnipod or other insulin patch pumps in some patients with diabetes.